---
accession : E-GEOD-57156
platform  : A-AFFY-44
pathway   : EGFR
cells     : PC-9 differentiated lung adenocarcinoma cell line
treatment : Erlotinib
effect    : inhibiting
hours     : 24

control   :
    - GSM1376320 1
    - GSM1376321 1
treatment :
    - GSM1376322 1
    - GSM1376323 1

---
accession : E-GEOD-57156
platform  : A-AFFY-44
pathway   : EGFR
cells     : HCC4006 lung cell line derived from pleural effusion
treatment : Erlotinib
effect    : inhibiting
hours     : 24

control   :
    - GSM1376324 1
    - GSM1376325 1
treatment :
    - GSM1376326 1
    - GSM1376327 1

---
accession : E-GEOD-57156
platform  : A-AFFY-44
pathway   : EGFR
cells     : HCC2279 lung cancer cell line
treatment : Erlotinib
effect    : inhibiting
hours     : 24

control   :
    - GSM1376328 1
    - GSM1376329 1
treatment :
    - GSM1376330 1
    - GSM1376331 1

---
accession : E-GEOD-57156
platform  : A-AFFY-44
pathway   : EGFR
cells     : HCC2935 lung pleural effusion cell line
treatment : Erlotinib
effect    : inhibiting
hours     : 24

control   :
    - GSM1376332 1
    - GSM1376333 1
treatment :
    - GSM1376334 1
    - GSM1376335 1
...
